Relationship Details

This document is a Table of Contents for a confidential investment memorandum or offering document related to New Leaf Venture Partners and the healthcare sector. It outlines sections regarding historical performance, investment strategy, and an ongoing relationship with Sprout Funds. The page bears a House Oversight Bates stamp, indicating it is part of a congressional investigation.

This document is a confidential financial chart titled 'Returns by Fund' as of March 31, 2014, bearing a House Oversight stamp. It details the performance metrics (IRR, Multiples, Capital) for six funds: Growth II HCT, Sprout VII HCT, Sprout VIII HCT, Sprout IX HCT, NLV-I, and NLV-II. The chart compares these funds against public indices like the S&P 500 and Nasdaq, showing significant distributed capital totaling over $1 billion for the largest fund listed.

This document is a confidential financial report summarizing the investment performance of New Leaf Ventures and Sprout Funds by sector as of March 31, 2014. It details performance metrics (Gross Value, Multiple, and IRR) for Biopharmaceutical and Information Convergence investments across multiple funds dating back to 1993. The document carries a House Oversight Committee stamp, indicating it was part of a congressional investigation.